Porphyria cutanea tarda. Update 1978.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects; D006581:Hexachlorobenzene / Q000009:adverse effects; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications; D011078:Polychlorinated Biphenyls / Q000009:adverse effects; D000072317:Polychlorinated Dibenzodioxins / Q000009:adverse effects; D011164:Porphyrias / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D014575:Uroporphyrinogen Decarboxylase / Q000378:metabolism; D014578:Uroporphyrins / Q000652:urine
D000900:Anti-Bacterial Agents; D000962:Antimalarials; D004967:Estrogens; D000072317:Polychlorinated Dibenzodioxins; D014578:Uroporphyrins; D006581:Hexachlorobenzene; D011078:Polychlorinated Biphenyls; D014575:Uroporphyrinogen Decarboxylase